MKI67 and cancer: The expressions of Ki67, which is the proliferative index of cancer cells, and the CSC markers were also dramatically reduced in the GalNac‐siHK2 treatment group compared with the GalNac‐siNC treatment group (Figure 7f and Figure S7f–h, Supporting Information).